The 26th CPHI China grandly opened at Shanghai NewInternational Expo Centre on June 15, 2026. Chongqing Chinabase participated inthe exhibition with a comprehensive lineup of pharmaceutical activepharmaceutical ingredients (APIs), pharmaceutical intermediates, and healthfood raw materials.

At this exhibition, ChongqingChinabase featured a wide range of popular API products including Alpha-GPC as keyhighlights. Boasting exceptional purity levels, rigorous impurity control andstable physicochemical properties, this product series drew numerous inquiriesand in-depth negotiations from domestic and overseas buyers on-site, emergingas the star products of this year’s trade show.Notably, a number of core APIsfor which Chongqing Chinabase has driven in-depth process improvement not onlycomply with stringent standards set forth by pharmacopoeias of multiplecountries, but also effectively help downstream formulation manufacturersshorten R&D cycles and mitigate environmental and production risks. Theirhigh purity and superior stability perfectly meet the stringent demand forpremium raw materials in regulated markets worldwide.

During the exhibition, Chongqing Chinabase drewcrowds of new and existing domestic and overseas customers who stopped by forexchanges. Moreover, the company further consolidated its long-term strategiccooperation with major international manufacturers from Japan, South Korea andother regions.

To date, more than ten potential internationalpartners with promising cooperation intentions have arranged to conductthorough reviews on the technical documents of Chongqing Chinabase’s coreproducts (including DMF, COA,etc.) as well as relevant qualifications after theexhibition. Factory site visits and joint audits have also been scheduled inthe near term.